Principles of human teratology: drug, chemical, and infectious exposure (Q34584497)

3 August 2017

Principles of human teratology: drug, chemical, and infectious exposure (English)

1 reference

3 August 2017

Marc Steben

16

0 references

Anne O. Summers

3

object named as

Anne Summers

1 reference

3 August 2017

14

Julie van Schalkwyk

1 reference

3 August 2017

11

Andrée Gruslin

1 reference

3 August 2017

R Douglas Wilson

1

1 reference

3 August 2017

Jo-Ann Johnson

2

1 reference

3 August 2017

Phil Wyatt

4

1 reference

3 August 2017

Victoria Allen

5

1 reference

3 August 2017

Alain Gagnon

6

1 reference

3 August 2017

Sylvie Langlois

7

1 reference

3 August 2017

Claire Blight

8

1 reference

3 August 2017

Deborah M Money

9

1 reference

3 August 2017

Marc Boucher

10

1 reference

3 August 2017

Catherine Jane Mackinnon

12

1 reference

3 August 2017

Caroline Paquet

13

1 reference

3 August 2017

Howard Ronald Cohen

15

1 reference

3 August 2017

Thomas Wong

17

1 reference

3 August 2017

Mark Harris Yudin

18

1 reference

3 August 2017

Society of Obstetricians and Gynecologists of Canada

19

1 reference

3 August 2017

1 November 2007

1 reference

Journal of Obstetrics and Gynaecology Canada

3 August 2017

1 reference

3 August 2017

29

1 reference

3 August 2017

11

1 reference

3 August 2017

911-926

1 reference

Unintended Pregnancy in the United States

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Unintended pregnancies and exposure to potential human teratogens

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Prescription drug use in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Use of over-the-counter medications during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Do no harm: avoidance of herbal medicines during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Teratology society: presentation to the FDA public meeting on safety issues associated with the use of dietary supplements during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Detection of viral deoxyribonucleic acid in amniotic fluid: association with fetal malformation and pregnancy abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Identifying fetal alcohol spectrum disorder in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Antiepileptic drug use of women with epilepsy and congenital malformations in offspring

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

The Outcome of 150 Babies Following the Treatment With Letrozole or Letrozole and Gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

The use of selective serotonin reuptake inhibitors in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Risks associated with selective serotonin reuptake inhibitors in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Risk of fetal exposure to tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Teratogen update: lead and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Pregnancy outcomes after maternal exposure to simvastatin and lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Anomalies associated with failed methotrexate and misoprostol termination

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

A survey of pregnant women using isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

In utero exposure to coumarins and cognition at 8 to 14 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Motherisk rounds. Warfarin embryopathy following low-dose maternal exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Prenatal and congenital syphilis in British Columbia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Prenatal diagnosis of congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

1 reference

7 January 2021

Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Previous maternal infection with Toxoplasma gondii and the risk of fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

1 reference

7 January 2021

Monitoring congenital rubella embryopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Focal sonographic periventricular pattern associated with mild ventriculomegaly in foetal cytomegalic infection revealing cytomegalic encephalitis in the third trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Is fetal gender a risk factor for severe congenital cytomegalovirus infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Immunotherapy for congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Fetal parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Fetal parvovirus B19 infection: Doppler studies allow noninvasive treatment of ascites

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Parvovirus B19 infection: fifth disease and more

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome: correlation with pathology findings

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Challenges in the diagnosis and management of neonatal herpes simplex virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

Genital herpes complicating pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932668-8

7 January 2021

10.1016/S1701-2163(16)32668-8

Identifiers

DOI

0 references

1 reference